Leadership

Mr. Donghoon Lee is the Chief Executive Officer and President of SK Biopharmaceuticals and its U.S. subsidiaries SK Life Science, Inc. and SK Life Science Labs. His vision is to transform all three companies so that together they become a global biotech leader while generating synergy with SK Group, its affiliates, and partners. Previously, Mr. […]

Sunita Misra, MD, PhD joined the SK Life Science, Inc. team in 2023 initially supporting the ongoing clinical studies. Her deep experience as a clinician and researcher in pediatric epilepsy has enabled Dr. Misra to guide the organization’s clinical development strategy.

Lisa is an accomplished commercial leader with a proven track record of driving growth and building high-performing teams across the pharmaceutical and medical device industries. She brings extensive experience across multiple therapeutic categories and has successfully launched products, expanded market share, and consistently exceeded targets in highly competitive environments.

As the Vice President and Global Head of Regulatory Affairs at SK Life Science, Darshan brings a wealth of knowledge and experience to our leadership team. During his 20 years in the pharmaceutical industry, Darshan has led several regulatory affairs and pharmacovigilance teams at various pharmaceutical companies, concentrating on the development of treatments for CNS and cardiovascular disorders.

Hina Patel joined SK Life Science, Inc. as Vice President and Global Head of Quality Assurance and Document Management in 2011. With nearly three decades of experience in research and development and commercial quality, Hina has demonstrated expertise and knowledge in navigating the complex landscape of regulatory compliance, and drug development.

Josh McLaughlin joined SK Life Science, Inc. in 2020 and is the Company’s General Counsel and Head of Legal and Compliance. With a deep knowledge of the industry and strong history of legal leadership, Josh plays a critical role in guiding our organization’s legal strategy and ensuring compliance across all aspects of our operations.

Jaclyn Ancora joined SK Life Science, Inc. in 2019, and serves as Vice President, Human Resources. She and her team are focused on delivering a strategy that emphasizes individual career growth while maintaining the needs of the business, ensuring that the HR team’s initiatives are aligned with the Company’s goals and core values. Throughout her […]

Jason Kim is a seasoned financial executive with a diverse background spanning strategic finance, investment management, and corporate leadership. Currently serving as Chief of Staff, and VP Corporate Center, Jason oversees Project Management, TA Group, and Facilities and Information Technology at SK Life Science, Inc. ensuring streamlined operations across the board.

Kristina Stracco joined SK Life Science, Inc. in 2019 and is currently Vice President of Market Access, Trade, and Patient Services. She brings more than two decades of experience across market access, pricing, trade, and financial operations within the pharmaceutical industry. Kristina and her team are dedicated to ensuring that patients can both access and afford SK Life Science’s products.

Keun Yong “Austin” Cho brings a wealth of expertise to SK Life Science as Vice President of Commercial.

Kris Lee is an accomplished biopharmaceutical executive with more than 25 years of experience spanning global supply chain management, commercial manufacturing, product launches, strategic partnerships, and commercial operations. Currently serving as Vice President of Global Supply & Manufacturing at SK Life Science, Inc., Kris oversees Global Supply Chain Management and Commercial Production Management activities across SK Life Science and SK Biopharmaceuticals in the United States and Korea.

Mike Polito joined SK Life Science, Inc. in 2019 and is currently the VP, Head of Finance. With a career in finance spanning over 30 years, Mike brings immense accounting and finance acumen and analytical skills to SK Life Science, Inc. to help lead its finance and accounting team.

David F. Cook, PhD, serves as Vice President of Medical Affairs, where he leads the strategic direction and execution of the Medical Affairs function in close partnership with cross-functional teams across the organization.

Kiel Kim is a Vice President, Global Business Development of SK Life Science Inc. as well as the Chief Business Officer, Chief Operating Officer, and board member of SK Life Science Labs. He is responsible for executing the vision of growing SK Life Science Labs into a global biotech company. Previously, Mr. Kim was the […]

Woojin Choi joined the SK Life Science, Inc. family in the fall of 2025 as Vice President of Business Development (BD). Woojin brings a differentiated skillset and deep industry network to our leadership team with over two decades of investment banking experience from several leading global financial institutions.

Changho Yu joined SK Biopharmaceuticals Co., Ltd., and its subsidiary, SK Life Science, in 2002. During his 20-year tenure, Mr. Yu has become an integral leader who brings a wealth of knowledge and experience to the Strategy and Investment business function.

Jiyoung Jung joined SK Biopharmaceuticals Co., Ltd. in 2017 and currently serves as Vice President and Chief Finance Officer of SK Biopharmaceuticals and SK Life Science, Inc. With more than two decades of experience in finance across SK Group, Mr. Jung provides strategic financial leadership to support the company’s sustainable growth and global expansion. He also serves as an executive director of SK Biopharmaceuticals.

Taeho Kim is an accomplished neuroscience drug discovery leader with extensive experience advancing disease-modifying therapies for neurodegenerative and rare neurological disorders. Taeho previously worked at Novartis, where he led cross-functional teams and modality-agnostic portfolios from early discovery through clinical entry, while helping shape strategy in areas including Huntington’s and Alzheimer’s disease.

Chris Lee joined SK Life Science Inc. in May 2025 as Executive Director, Head of CMC and Clinical Supply. He brings over 20 years of experience in CMC development and commercialization within the biopharmaceutical industry.

Dr. Shin is deeply passionate about fostering innovation by bridging AI with diverse domains, notably biotechnology and novel drug development.